George Whitesides
Tickers in This Filing
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsGeorge Whitesides sold $100K-$250K of Home Depot (HD) on 2025-03-24, 3 days before the 'Revitalizing Downtowns and Main Streets Act' (HR2410) was introduced, which proposes an investment tax credit for converting non-residential buildings.
George Whitesides sold $100K-$250K of Coca-Cola Company (KO) on 2025-03-24, 7 days before the 'Sarah Katz Caffeine Safety Act' (HR2511) was introduced, proposing new labeling requirements for caffeinated products.
George Whitesides sold $50K-$100K of $JP Morgan Chase (JPM) and $15K-$50K of Bank of America (BAC) on 2025-03-24, 8 days before the 'Sanctioning Russia Act of 2025' (HR2548) was introduced, proposing financial and trade restrictions.
George Whitesides sold $100K-$250K of Johnson & Johnson (JNJ) on 2025-03-24, 17 days before the 'ABC Safe Drug Act' (S1407) was introduced, which aims to restrict certain pharmaceutical fees.
George Whitesides sold $250K-$500K of Microsoft (MSFT) on 2025-03-24, 24 days before the 'Addressing Boarding and Crowding in the Emergency Department' (HR2936) was introduced, proposing grants for tracking hospital bed capacity.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| SELL | $INVA | Innoviva, Inc. - Common Stock (INVA) [ST] | $250K-$500K | — | — | — | Mar 25, 2025 |
| SELL | $MSFT | Microsoft Corporation - Common Stock (MSFT) [ST] | $250K-$500K | — | — | — | Mar 24, 2025 |
| SELL | $CB | Chubb Limited Common Stock (CB) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $KO | Coca-Cola Company (KO) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $HD | Home Depot, Inc. (HD) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $JNJ | Johnson & Johnson Common Stock (JNJ) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $LIN | Linde plc - Ordinary Shares (LIN) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $MMC | Marsh & McLennan Companies, Inc. Common Stock (MMC) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $MCD | McDonald's Corporation Common Stock (MCD) [ST] | $100K-$250K | — | — | — | Mar 24, 2025 |
| SELL | $NFLX | Netflix, Inc. - Common Stock (NFLX) [ST] | $100K-$250K | — | — | — | Mar 27, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
ABC Safe Drug Act
The ABC Safe Drug Act (S. 1407) is in early legislative stages, having been referred to the Senate Finance Committee. It phases in restrictions on federal health programs purchasing drugs with Chinese active ingredients by 2030 and provides temporary tax incentives for domestic pharmaceutical manufacturing. Major pharma stocks ($PFE, $MRK, $JNJ, $LLY, $AMGN) show mixed but broadly negative 7-day changes, reflecting sector headwinds rather than this nascent bill. No market-moving impact is imminent.
Sanctioning Russia Act of 2025
HR2548 (Sanctioning Russia Act of 2025) is a stalled bill referred to committee over a year ago with no further legislative action. It authorizes no spending and imposes no current obligations. Recent price moves in energy and bank stocks are driven by macroeconomic factors and executive orders, not this bill. Impact is effectively zero.
Expanded Student Saver’s Tax Credit Act
HR2852 (Expanded Student Saver's Tax Credit Act) is an early-stage bill that would allow full-time students to claim the Saver's Credit and later the Saver's Match. The bill has zero appropriated funding — it modifies eligibility rules only. With just 2 cosponsors and referral to the Ways and Means Committee, it faces a long legislative path. The market impact on financial sector stocks is negligible. No executive action from April 20, 2026 is relevant to this bill.
Flexible Savings Arrangements for a Healthy Robust America Act
HR2667 would allow FSA/HRA funds to roll tax-free into HSAs upon HDHP enrollment, expanding the addressable market for HSA administrators and HDHP issuers. The bill is at early stage (referred to Ways and Means, no appropriations). Recent 30-day gains for UNH (+36.1%), HUM (+40.2%) and CVS (+16.4%) are driven by broader sector momentum, not this bill alone. Near-term market impact is limited due to early legislative stage.
Taiwan Allies Fund Act
The Taiwan Allies Fund Act (HR2559) is an early-stage authorization bill with $0 funding that has been stalled in the House Foreign Affairs Committee for over a year with no legislative action. It carries zero near-term market impact for any traded security, including TSM, which remains driven by semiconductor fundamentals and real appropriations bills like the CHIPS Act.
Sarah Katz Caffeine Safety Act
The Sarah Katz Caffeine Safety Act (HR2511) imposes new caffeine labeling and menu disclosure requirements on beverage manufacturers and restaurant chains. The bill is in early committee stage with no markup scheduled—near-term market impact is minimal. Pure-play energy drink company $MNST faces the highest relative compliance cost burden, while $SBUX faces menu redesign costs. Diversified giants $KO and $PEP have negligible relative impact.
Ellie’s Law
Ellie's Law (HR2678) is an early-stage authorization bill directing NINDS to research unruptured intracranial aneurysms. It authorizes zero dollars, has no funding appropriation, and has only been referred to committee. Market impact is negligible in the near term for device and research tool providers like MDT, TMO, ILMN, and DGX, as no actual spending exists and the legislative path is years from completion.
Providing Veterans Essential Medications Act
HR1970 (Providing Veterans Essential Medications Act) is in early legislative stages, having been referred to the House Veterans' Affairs subcommittee. The bill mandates VA reimbursement for high-cost medications dispensed to veterans in State nursing homes, but authorizes no specific funding and remains months from passage. Real market data shows CVS up 16% in 30 days while CAH is down 10%, reflecting broader distribution-sector dynamics rather than this early-stage bill.
Climate Change Financial Risk Act of 2025
The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.
Revitalizing Downtowns and Main Streets Act
HR2410, the Revitalizing Downtowns and Main Streets Act, proposes a 20% tax credit for converting non-residential buildings into affordable housing. Introduced March 27, 2025, it remains in early legislative stages in the House Ways and Means Committee with no near-term market impact. Monitored homebuilders ($LEN, $DHI, $PHM, $KBH, $NVR) show neutral direct exposure; real beneficiaries would be commercial real estate owners and adaptive reuse developers not represented in this ticker set.
Other Filings by George Whitesides
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.